The Week Ahead: Kingfisher, B&Q, Next
18th March 2022 11:29
by Richard Hunter from interactive investor
There are plenty of results for investors to watch out for in the days ahead. Our head of markets runs through what he thinks will be the highlights.
- Ian Cowie: China is cheap, but I prefer India and Vietnam
- Bank of England raises interest rates again to battle inflation surge
- Video: Russia, Ukraine and the mining sector
- Commodities shock: wild times as scarcity looms
- Video: inflation, dividends and a new commodities supercycle
Monday 21 March
Trading statements
Photo-Me International, Spectral MD Holdings, Sthree
AGM/EGM
Aferian, Altona Rare Earths, Helical, Inland Homes
Tuesday 22 March
Trading statements
Alliance Pharma, BioPharma Credit, Circassia, Diaceutics, Diurnal, IQGeo Group, Kingfisher (LSE:KGF), Longboat Energy, Luceco, MaxCyte, MP Evans, Oxford Nanopore Technologies, Pebble Group, Real Estate Investors, Sabre Insurance, ScS Group, Softcat, Staffline, Trustpilot Group (LSE:TRST), YouGov, Zotefoams
AGM/EGM
Crest Nicholson, Hochschild Mining, Hydro Hotel Eastbourne, Starvest, Sureserve, Wynnstay
Wednesday 23 March
Trading statements
Dignity, ECSC Group, Henry Boot, Judges Scientific, Pendragon, Saga (LSE:SAGA), SigmaRoc
AGM/EGM
CML Microsystems, Quartix Technologies, Strategic Equity Capital
Thursday 24 March
Companies scheduled to begin trading without the right to the latest dividend include British American Tobacco (LSE:BATS), Greggs (LSE:GRG), Pearson (LSE:PSON) and Prudential (LSE:PRU)
Trading statements
Arbuthnot Banking Group, Atalaya Mining, Big Technologies, Biome Technologies, Bonhill Group, Bridepoint, CVS Group, Energean, EnQuest, Eve Sleep, International Public Partnerships, Kin & Carta, Next (LSE:NXT), Safestyle UK, Secure Trust Bank, Sopheon, Starwood European Real Estate, AG Payment Solutions
AGM/EGM
BlackRock Throgmorton Trust, Independent Investment Trust, N4 Pharma, React Group
Friday 25 March
Trading statements
Ebiquity, Faron Pharmaceuticals OY
AGM/EGM
Beazley, Kitwave, PCF Group
These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.